Debbie's Place

A Patient's Point of View

ANANDAMIDE/ AEA – endocannabinoid, CB 1 & 2 agonist

 ANANDAMIDE/ AEA – endocannabinoid, CB 1 & 2 agonist

 

Phytocannabinoids                      (news – undated)

http://www.news-medical.net/health/Phytocannabinoids.aspx

 

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor. (abst – 1992)                                          http://www.ncbi.nlm.nih.gov/pubmed/1470919

 

Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agentsCP 55,940, WIN 55,212-2 and anandamide.                                                           (full – 1993)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2175863/?tool=pmcentrez&page=1

 

Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction                                                            (full – 1993)   http://www.pnas.org/content/90/16/7656.full.pdf+html

 

Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent.    (abst – 1993)                                       http://www.ncbi.nlm.nih.gov/pubmed/8384116

 

Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes    (full – 1994)                                         http://www.pnas.org/content/91/14/6698.full.pdf+html

 

Formation and inactivation of endogenous cannabinoid anandamide in central neurons. (letter – 1994)                                             http://www.nature.com/nature/journal/v372/n6507/abs/372686a0.html

 

Formation and inactivation of endogenous cannabinoid anandamide in central neurons (abst – 1994)                                           http://www.nature.com/nature/journal/v372/n6507/abs/372686a0.html

 

Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization.           (full – 1995)                                    http://www.jbc.org/content/270/11/6030.long

 

Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin (abst – 1995)

 

http://ajpheart.physiology.org/cgi/content/abstract/269/6/H1859?maxtoshow=&hits=80&RESULTFORMA  T=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=2320&resourcetype=HWCIT

 

Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide.      (abst – 1995)                         http://www.ncbi.nlm.nih.gov/pubmed/7589169

 

The CB1 cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the rat.                                         (abst – 1995)       http://www.ncbi.nlm.nih.gov/pubmed/7488739

 

Marijuana and chocolate.             (abst – 1996)       http://www.ncbi.nlm.nih.gov/pubmed/11363932

 

Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain.                                                               (full – 1997)  http://www.jneurosci.org/content/17/4/1226.long

 

Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand            (full – 1997)  http://www.druglibrary.org/crl/receptors/endogenous/Goparahu%20et.al%2098%202-  AG_%20FEBSLet.pdf

 

Cannabinoid-Induced Hypotension and Bradycardia in Rats Is Mediated by CB1-Like Cannabinoid Receptors  (full – 1997)  http://jpet.aspetjournals.org/content/281/3/1030.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext

=cannabinoid&searchid=1&FIRSTINDEX=320&resourcetype=HWCIT

 

Patent 5631297 – Anandamides useful for the treatment of intraocular hypertension, ophthalmic compositions containing the same and methods of use of the same

(full – 1997)                     http://www.patentstorm.us/patents/5631297/fulltext.html

 

Anandamide : The molecule of extreme pleasure              (report– 1997)

http://www.chm.bris.ac.uk/motm/anandamide/ananh.htm

 

Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. (abst – 1997)                                       http://www.ncbi.nlm.nih.gov/pubmed/9394002

 

Brain Chemicals Mimic Marijuana (news – 1997)  http://www.ukcia.org/research/anandami.php

 

Anandamide, an Endogenous Cannabinoid, Has a Very Low Physical Dependence Potential       (full – 1998)  http://jpet.aspetjournals.org/content/287/2/598.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=  cannabinoid&searchid=1&FIRSTINDEX=480&resourcetype=HWCIT

 

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation (full – 1998)                                      http://www.ncbi.nlm.nih.gov/pmc/articles/PMC20983/

 

Cardiovascular actions of cannabinoids and their generation during shock.            (abst – 1998)

http://www.ncbi.nlm.nih.gov/pubmed/9846953

 

Trick or treat from food endocannabinoids?             (abst – 1998)

http://www.nature.com/nature/journal/v396/n6712/full/396636a0.html

 

Doped skin   (news – 1998)  (may need registration)

http://www.newscientist.com/article/mg15921434.700-doped-skin.html

 

Pain modulation by release of the endogenous cannabinoid anandamide             (full – 1999)

http://www.pnas.org/content/96/21/12198.full

 

Cannabis: Discrimination of “Internal Bliss”?              (abst – 1999)

http://www.ncbi.nlm.nih.gov/pubmed/10515300

 

Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors (abst – 1999)                                      http://link.springer.com/article/10.1007%2Fs002130050953

 

Brain Releases Marijuana-Like Substance In Response To Pain, Study Finds (news – 1999)                                      http://www.sciencedaily.com/releases/1999/10/991013074947.htm

 

Links found between marijuana and vision                (news – 1999)

http://archives.cnn.com/1999/HEALTH/12/07/science.marijuana/index.html

 

UC Irvine Researchers Demonstrate How Marijuana-Like Chemicals Work In The Brain (news – 1999)                                      http://www.sciencedaily.com/releases/1999/03/990323050735.htm

 

Why your brain is primed for a high             (news – 1999) (may need registration)

http://www.newscientist.com/article/mg16121792.000-why-your-brain-is-primed-for-a-high.html

 

Anandamide Induces Apoptosis in Human Cells via Vanilloid Receptors           (full – 2000)

http://www.jbc.org/content/275/41/31938.full

 

Endocannabinoids and Vascular Function             (full – 2000)

http://jpet.aspetjournals.org/content/294/1/27.long

 

Suppression of Nerve Growth Factor Trk Receptors and Prolactin Receptors by Endocannabinoids Leads to Inhibition of Human Breast and Prostate Cancer Cell Proliferation (full – 2000)                                   http://endo.endojournals.org/cgi/content/full/141/1/118

 

Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human (full – 2000)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1571997/?tool=pmcentrez

 

Cardiovascular effects of endocannabinoids–the plot thickens.              (abst – 2000)  http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=10785543&dopt=abstrac  tplus

 

Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice.                                                          (abst – 2000)  http://www.ncbi.nlm.nih.gov/pubmed/10762668

 

 

Endogenous cannabinoids and appetite.                (abst – 2000)

http://www.ncbi.nlm.nih.gov/pubmed/19087417

 

Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets.

(full – 2001)               http://www.ncbi.nlm.nih.gov/pmc/articles/PMC33480/?tool=pubmed

 

Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation                                               (full – 2001)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572987/?tool=pmcentrez

 

Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts                                                        (full – 2001)  http://cardiovascres.oxfordjournals.org/content/55/3/619.full?sid=750cba66-d3d1-484d-96e8-  04975ba34325

 

Inhibition of Rat C6 Glioma Cell Proliferation by Endogenous and Synthetic Cannabinoids. Relative Involvement of Cannabinoid and Vanilloid Receptors (full – 2001)         http://jpet.aspetjournals.org/content/299/3/951.full

 

Exogenous anandamide protects rat brain against acute neuronal injury in vivo. (full – 2001)                                  http://www.jneurosci.org/content/21/22/8765.long

 

Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats          (full – 2001)                  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573067/?tool=pmcentrez

 

Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase  and enhances the anti-proliferative effect of anandamide in human breast  cancer cells (full – 2001)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1222054/pdf/11485574.pdf/?tool=pmcentrez

 

Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries (full – 2001)                                  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573021/?tool=pmcentrez

 

Endogenous cannabinoids mediate hypotension after experimental myocardial infarction (full – 2001)  http://content.onlinejacc.org/cgi/content/full/38/7/2048?maxtoshow=&hits=80&RESULTFORMAT=&fullt   ext=cannabinoid&searchid=1&FIRSTINDEX=560&resourcetype=HWCIT

 

Anandamide activates peripheral nociceptors in normal and arthritic rat knee joints (full – 2001)                                    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572613/?tool=pmcentrez

 

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase                                                        (full – 2001)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC55427/?tool=pubmed

 

Administration of Endocannabinoids Prevents a Referred Hyperalgesia Associated With Inflammation of the Urinary Bladder                                                  (full – 2001)  http://journals.lww.com/anesthesiology/Fulltext/2001/03000/Administration_of_Endocannabinoids_Preven ts_a.23.aspx

 

Leptin-regulated endocannabinoids are involved in maintaining food intake (letter – 2001)                                   http://www.ncbi.nlm.nih.gov/pubmed/11298451

 

The neurobiology and evolution of cannabinoid signalling                 (abst – 2001)  http://rstb.royalsocietypublishing.org/content/356/1407/381.abstract?ijkey=3aad97283bf56bae0ada89fe6c2  5ef27a702e9ba&keytype2=tf_ipsecsha

 

Endogenous cannabinoid anandamide increases heart resistance to arrhythmogenic  effects of epinephrine: role of CB(1) and CB(2) receptors.                                                             (abst – 2001)  http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=11427912&dopt=abstrac tplus

 

The Central Cannabinoid Receptor Inactivation Suppresses Endocrine Reproductive Functions.  (abst – 2001)                                http://www.ncbi.nlm.nih.gov/pubmed/11394887

 

Quantification of anandamide content in animal cells and tissues: the normalization makes the difference            (full – 2002)                                     http://www.lipidworld.com/content/1/1/4

 

Endocannabinoid Degradation, Endotoxic Shock and Inflammation (link to PDF – 2002)                                                http://www.eurekaselect.com/91915/article

 

Sourcing the Code: Searching for the Evolutionary Origins of Cannabinoid Receptors, Vanilloid Receptors, and Anandamide                                                          (full – 2002)

http://www.cannabis-med.org/data/pdf/2002-01-3.pdf

 

Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation        (full – 2002)  http://bloodjournal.hematologylibrary.org/content/100/12/4040.full

 

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease            (full – 2002)  http://bloodjournal.hematologylibrary.org/cgi/content/full/100/2/627?ijkey=eb71d6d7a06f311440761cfac6   a7d081bcc2771d

 

A Peripheral Mechanism for CB1 Cannabinoid Receptor-Dependent Modulation of Feeding       (full – 2002)  http://www.jneurosci.org/cgi/content/abstract/22/21/9612?ijkey=328b5e83d7be9297b9483d22e0d6319fa0a 862e8&keytype2=tf_ipsecsha

 

Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission.                                                          (full – 2002)

http://www.jneurosci.org/content/22/16/6900.long

 

Anandamide uptake by synaptosomes from human, mouse and rat brain: inhibition by glutamine and glutamate  (full – 2002)                                            http://www.lipidworld.com/content/1/1/1

 

Endogenous cannabinoids improve myocardial resistance to arrhythmogenic effects of coronary occlusion and reperfusion: a possible mechanism.                                                      (abst – 2002)  http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=12428277&dopt=abstrac tplus

 

Endocannabinoids and related fatty acid derivatives in pain modulation.            (abst – 2002)

http://www.ncbi.nlm.nih.gov/pubmed/12505698

 

Anandamide and R-(+)-methanandamide prevent development of ischemic and reperfusion arrhythmia in rats by stimulation of CB2-receptors                                                                     (abst – 2002)  http://www.ncbi.nlm.nih.gov/pubmed/12227101

 

Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide. (abst – 2002)                                         http://www.ncbi.nlm.nih.gov/pubmed/12384227

 

Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine.                                             (abst – 2002)        http://www.ncbi.nlm.nih.gov/pubmed/12393235

 

Role of Endogenous Cannabinoids in Synaptic Signaling                (full – 2003)  http://physrev.physiology.org/cgi/content/full/83/3/1017?maxtoshow=&hits=80&RESULTFORMAT=&ful   ltext=cannabinoid&searchid=1&FIRSTINDEX=160&resourcetype=HWCIT

 

Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon         (full – 2003)  http://ajpgi.physiology.org/content/286/1/G110.full?sid=fc6948f0-78cf-405c-981b-afaa05ee417c

 

CB1 cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction (full – 2003)                                     http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573770/?tool=pmcentrez

 

Endocannabinoid signalling in the blood of patients with schizophrenia (full – 2003)                                                  http://www.lipidworld.com/content/2/1/5

 

A new endothelial target for cannabinoids.             (full – 2003)

http://molpharm.aspetjournals.org/content/63/3/469.long

 

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis                                                     (full – 2003)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC166293/

 

Endocannabinoids protect the rat isolated heart against ischaemia              (full – 2003)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573907/?tool=pmcentrez

 

Cannabis and the brain.   (full – 2003)            http://brain.oxfordjournals.org/cgi/content/full/126/6/1252

 

Chronic Morphine Modulates the Contents of the Endocannabinoid, 2-Arachidonoyl Glycerol, in Rat Brain       (full – 2003)  http://www.nature.com/npp/journal/v28/n6/full/1300117a.html

 

Manipulation of the endocannabinoid system by a general anaesthetic.             (full – 2003)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573927/?tool=pubmed

 

Cannabinoids inhibit neurodegeneration in models of multiple sclerosis               (full – 2003)  http://brain.oxfordjournals.org/cgi/content/full/126/10/2191?ijkey=c7c6bfd158b85c98cb1a190d5ca261455  2989ba0

 

Therapeutic potential of cannabinoids in CNS disease.              (abst – 2003)

http://www.ncbi.nlm.nih.gov/pubmed/12617697

 

Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production. (abst – 2003)    http://www.ncbi.nlm.nih.gov/pubmed/12746841?dopt=Abstract

 

Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: variability in response and involvement of arachidonic acid. (abst – 2003)                                              http://www.ncbi.nlm.nih.gov/pubmed/12948856

 

Therapeutic potential of cannabinoids in CNS disease.              (abst – 2003)

http://www.ncbi.nlm.nih.gov/pubmed/12617697

 

Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716. (abst – 2003)                                     http://www.ncbi.nlm.nih.gov/pubmed/12447606

 

An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice.    (abst – 2003)                     http://www.ncbi.nlm.nih.gov/pubmed/12949722

 

Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study.                                              (abst – 2003)  http://www.ncbi.nlm.nih.gov/pubmed/14746372?dopt=Abstract

 

The endocannabinoid system: a general view and latest additions             (full – 2004)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574255/?tool=pmcentrez

 

Endocannabinoids: Getting the message across             (full – 2004)  http://www.pnas.org/content/101/23/8512.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=can  nabis&searchid=1&FIRSTINDEX=2880&resourcetype=HWCIT

 

Endocannabinoids and Their Implications for Epilepsy               (full – 2004)

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1176361&tool=pmcentrez

 

Anandamide Is Able to Inhibit Trigeminal Neurons Using an in Vivo Model of Trigeminovascular-Mediated Nociception                                                                (full – 2004)  http://jpet.aspetjournals.org/content/309/1/56.full

 

 

The complexities of the cardiovascular actions of cannabinoids                (full – 2004)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574918/?tool=pmcentrez

 

Up-Regulation of Cyclooxygenase-2 Expression Is Involved in R(_)-Methanandamide- Induced Apoptotic Death of Human Neuroglioma Cells                                                          (full – 2004)  http://science.iowamedicalmarijuana.org/pdfs/cancer/Hinz%202004.pdf

 

Involvement of cannabinoid receptors in gut motility and visceral perception (full – 2004)                                     http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574910/?tool=pmcentrez

 

Plasma Levels of the Endocannabinoid Anandamide in Women—A Potential Role in Pregnancy Maintenance and Labor?                                                             (full – 2004)  http://jcem.endojournals.org/cgi/content/full/89/11/5482?ijkey=5e8ec5690352ba9f6b990355b2ed69b1d2e5 8a5b

 

Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1                                                (full – 2004)  http://science.iowamedicalmarijuana.org/pdfs/cancer/Contassot%202004.pdf

 

A Cyclooxygenase Metabolite of Anandamide Causes Inhibition of Interleukin-2 Secretion in Murine Splenocytes                                                                     (full – 2004)  http://jpet.aspetjournals.org/content/311/2/683.full

 

Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172.                                                          (full – 2004)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC423268/

 

Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes.        (abst – 2004)                                    http://www.ncbi.nlm.nih.gov/pubmed/16574988

 

How our brains fend off madness, we produce a cannabis like substance           (news – 2004)

http://www.medicalnewstoday.com/releases/12516.php

 

Easing anxiety with anandamide               (news – 2004)

http://www.rsc.org/chemistryworld/Issues/2004/July/anandamide.asp

 

Exercise activates the endocannabinoid system.              (abst – 2004)

http://www.ncbi.nlm.nih.gov/pubmed/14625449

 

Study links marijuana buzz to ‘runner’s high’                (news – 2004)

http://www.cnn.com/2004/HEALTH/01/11/marijuana.exercise.reut/

 

Runner’s High  (news – 2004)

http://www.runnersworld.com/article/0%2C7120%2Cs6-243-297–1102-0%2C00.html

 

Prescription Chocolate              (news – 2004)      http://chocolate.org/health/chocprescribe.html

 

Cardiovascular Pharmacology of Cannabinoids                  (full – 2005)

 

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228270/?tool=pmcentrez

 

The cardiovascular actions of anandamide: more targets?               (full – 2005)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576182/?tool=pmcentrez

 

Cannabinoids promote hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects          (full – 2005)                                             http://www.jci.org/cgi/content/full/115/11/3104

 

Antidepressant-like Activity and Modulation of Brain Monoaminergic Transmission by Blockade of Anandamide Hydrolysis.                                                       (full – 2005)  http://www.pnas.org/content/102/51/18620.long

 

Blood pressure regulation by endocannabinoids and their receptors               (full – 2005)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225528/?tool=pmcentrez

 

The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2                                                        (full – 2005)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774787/?tool=pmcentrez

 

The effects of Δ9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide                                                            (full – 2005)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576168/?tool=pmcentrez

 

Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia–reperfusion by a novel cannabinoid mechanism                                                         (full – 2005)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751211/?tool=pmcentrez

 

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity                                              (full – 2005)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1087161/?tool=pmcentrez

 

Antidepressant-like activity by blockade of anandamide hydrolysis             (full – 2005)

http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=16352709

 

Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa.                                                       (full – 2005)  http://www.nature.com/npp/journal/v30/n6/full/1300695a.html

 

Analgesia through endogenous cannabinoids                 (full – 2005)  http://www.cmaj.ca/cgi/content/full/173/4/357?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=end  ocannabinoid&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=date&resourcetype=HW   CIT

 

Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors                                                         (full – 2005)  http://gut.bmj.com/content/54/4/522.full?sid=0731f0e5-2071-4549-be57-57f444307138

 

Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N- arachidonoyldopamine (NADA) in the rat isolated aorta.                                                                          (abst – 2005)

 

http://www.ncbi.nlm.nih.gov/pubmed/15659311

 

Targeted lipidomics: fatty acid amides and pain modulation.               (abst – 2005)

http://www.ncbi.nlm.nih.gov/pubmed/16099389

 

Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus (abst – 2005)                                    http://www.sciencedirect.com/science/article/pii/S0028390805001668

 

Influence of Anandamide, the Endogenous Agonist of Cannabinoid Receptors on the Circulatory System                                             (abst – 2005)          http://www.ncbi.nlm.nih.gov/pubmed/15928605

 

Finding of endocannabinoids in human eye tissues: implications for glaucoma. (abst – 2005)                                      http://www.ncbi.nlm.nih.gov/pubmed/15823551

 

Chocolate and cannabis           (article – 2005)  http://www.cannabisculture.com/articles/4337.html

 

A biosynthetic pathway for anandamide                (full – 2006)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557387/

 

Activation of G-proteins in brain by endogenous and exogenous cannabinoids. (full – 2006)                                     http://www.ncbi.nlm.nih.gov/pubmed/16584117

 

Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and ß-Pancreatic Cells and in Obesity and Hyperglycemia                                                        (full – 2006)  http://jcem.endojournals.org/cgi/content/full/91/8/3171?ijkey=83a68cef202eafe129332eda53eee8eb613499 82

 

Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P                                                                    (full – 2006)       http://gut.bmj.com/content/55/7/946.full

 

Endocannabinoids, feeding and suckling – from our perspective               (full – 2006)

http://www.nature.com/ijo/journal/v30/n1s/full/0803274a.html

 

Stage-variations of anandamide hydrolase activity in the mouse uterus during the natural oestrus cycle  ( full – 2006)                                                       http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1440866/?tool=pubmed

 

Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice                                                          (full – 2006)         http://www.fasebj.org/cgi/content/full/20/7/1003

 

Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation.                                                    (full – 2006)  http://www.fasebj.org/content/early/2006/03/01/fj.05-4943fje.long

 

Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection          (full – 2006)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1458883/?tool=pmcentrez

 

Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor- mediated excitotoxic damage                                                 (full – 2006)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751782/?tool=pmcentrez

 

Inhibition of Salivary Secretion by Activation of Cannabinoid Receptors            (full – 2006)  http://ebm.rsmjournals.com/cgi/content/full/231/8/1421?maxtoshow=&hits=80&RESULTFORMAT=&full   text=cannabinoid&searchid=1&FIRSTINDEX=880&resourcetype=HWCIT

 

Not Too Excited? Thank Your Endocannabinoids              (full – 2006)

http://www.sciencedirect.com/science/article/pii/S0896627306005927

 

Effect of N-arachidonoyl-(2-methyl-4-hydroxyphenyl) amine (VDM11), an anandamide transporter inhibitor, on capsaicin-induced cough in mice                                                        (full – 2006)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1448189/?tool=pmcentrez

 

Effects of general anesthesia on anandamide blood levels in humans.              (full – 2006)  http://journals.lww.com/anesthesiology/Fulltext/2006/02000/Effects_of_General_Anesthesia_on_Anandam  ide_Blood.12.aspx

 

Cannabinoids and the Endocannabinoid System              (full – 2006)

http://www.cannabis-med.org/english/journal/en_2006_01_2.pdf

 

Is there a temperature-dependent uptake of anandamide into cells?            ( full – 2006)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1629410/

 

A new strategy to block tumor growth by inhibiting endocannabinoid inactivation. (full – 2006)                                  http://www.fasebj.org/content/early/2004/10/02/fj.04-1754fje.long

 

Anxiolytic-like properties of the anandamide transport inhibitor AM404.              (full – 2006)

http://www.nature.com/npp/journal/v31/n12/full/1301061a.html

 

EFFECT OF CANNABINOIDS ON TESTICULAR ISCHEMIA-REPERFUSION INJURY IN RAT (full – 2006)

http://journals.tums.ac.ir/upload_files/pdf/_/3279.pdf

 

The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells.                                                                       (abst – 2006)  www.ncbi.nlm.nih.gov/pubmed/16387640

 

Methods evaluating cannabinoid and endocannabinoid effects on gastrointestinal functions.        (abst – 2006)                               http://www.ncbi.nlm.nih.gov/pubmed/16506408

 

Role of cannabinoid receptor agonists in mechanisms of suppression of central pain syndrome.    (abst – 2006)  http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=17369898&dopt=abstrac tplus

 

Anandamide inhibits adhesion and migration of breast cancer cells.             (abst – 2006)

http://www.ncbi.nlm.nih.gov/pubmed/16343481?dopt=Abstract

 

Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain                                                                           (abst – 2006)  http://www.ncbi.nlm.nih.gov/pubmed/16480822

 

Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations.                                                         (abst – 2006)  http://www.ncbi.nlm.nih.gov/pubmed/16899063

 

Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2- arachidonoylglycerol.                                              (abst – 2006)    http://www.ncbi.nlm.nih.gov/pubmed/16949718

 

Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels.                                                              (abst – 2006)  http://www.ncbi.nlm.nih.gov/pubmed/16732431

 

Release of anandamide from blood cells                (abst – 2006)  http://www.degruyter.com/abstract/j/cclm.2006.44.issue-  4/cclm.2006.065/cclm.2006.065.xml?rskey=jSEJyD&result=7&q=cannabinoid

 

UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington’s disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders.                                                                                             (abst – 2006)  http://www.ncbi.nlm.nih.gov/pubmed/16006105

 

Metabolism of Anandamide an Endogenous Cannabinoid                 (chart – 2006)  http://pid.nci.nih.gov/search/pathway_landing.shtml?source=BioCarta%20Imported&what=graphic&jpg=o   n&ppage=1&pathway_id=cb1rpathway

 

Anandamide, an endocannabinoid, protects neurons from inflammation after brain damage          (news – 2006)  http://www.xagena.it/news/medicinenews_net_news/9c25dc28b94e5226f1983330dc421cec.html

 

Anandamide Regulates Keratinocyte Differentiation by Inducing DNA Methylation in a CB1 Receptor-dependent Manner                                                      (full – 2007)     http://www.jbc.org/content/283/10/6005.full

 

Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury (full – 2007)                                  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228252/?tool=pmcentrez

 

Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain   (full – 2007)                   http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190014/?tool=pubmed

 

Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors.    (full – 2007)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2083705/?tool=pubmed

 

Anandamide Regulates Keratinocyte Differentiation by Inducing DNA Methylation in a CB1 Receptor-dependent Manner                                                          (full – 2007)

 

http://www.jbc.org/content/283/10/6005.full?sid=931583b1-e797-43e0-8296-7fd75bb49403#sec-4

 

Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson’s disease: role of CB1 and TRPV1 receptors                                                  (full – 2007)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2128772/?tool=pmcentrez

 

Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances ‘liking’ of a sweet reward.                                                                          (full – 2007)  http://www.nature.com/npp/journal/v32/n11/full/1301376a.html

 

Identification of Endocannabinoids and Related Compounds in Human Fat Cells (full – 2007)                                   http://onlinelibrary.wiley.com/doi/10.1038/oby.2007.581/full

 

Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats (full – 2007)                                   http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190006/?tool=pmcentrez

 

Endocannabinoids and the haematological system               (full – 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190025/?tool=pmcentrez

 

Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta           (full – 2007)                  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190007/?tool=pubmed

 

GPR55 and the vascular receptors for cannabinoids.              (full – 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190021/?tool=pubmed

 

The CB1 Cannabinoid Receptor Mediates Excitotoxicity-induced Neural Progenitor Proliferation and Neurogenesis                                                               (full – 2007)      http://www.jbc.org/content/282/33/23892.full

 

The orphan receptor GPR55 is a novel cannabinoid receptor.               (full – 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2095107/?tool=pubmed

 

Chronologically overlapping occurrences of nicotine-induced anxiety- and depression- related behavioral symptoms: effects of anxiolytic and cannabinoid drugs

(full – 2007)               http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2075518/?tool=pubmed

 

Involvement of the Endocannabinoid System in Retinal Damage after High Intraocular Pressure–Induced Ischemia in Rats                                                             (full – 2007)  http://www.iovs.org/cgi/content/full/48/7/2997?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=can  nabis&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HWCIT

 

Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of thioredoxin 1/redox factor 1 and AP-1 activation                                                                           (full – 2007)  http://ajpgi.physiology.org/content/294/2/G506.full

 

Opposing Actions of Endocannabinoids on Cholangiocarcinoma Growth (full – 2007)                                   http://www.jbc.org/content/282/17/13098.full

 

The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3′- carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice. (full – 2007)                                    http://jpet.aspetjournals.org/content/322/1/236.long

 

Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase.                                                              (full – 2007)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225473/?tool=pubmed

 

Endocannabinoids, cannabinoid receptors and inflammatory stress: an interview with Dr. Pál Pacher       (interview – 2007)  http://www.jleukbio.org/cgi/content/full/82/6/1390?maxtoshow=&hits=80&RESULTFORMAT=&fulltext

=cannabinoid&searchid=1&FIRSTINDEX=880&resourcetype=HWCIT

 

The endocannabinoids anandamide and 2-arachidonoylglycerol inhibit cholinergic contractility in the human colon.  (abst – 2007)  http://www.ncbi.nlm.nih.gov/pubmed/17706636

 

Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients (abst – 2007)

http://www.unboundmedicine.com/medline/ebm/record/17566707/abstract/Anandamide_levels_in_cerebro spinal_fluid_of_first_episode_schizophrenic_patients:_Impact_of_cannabis_use

 

Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor- suppressor efficacy.                                                  (abst – 2007)        http://www.ncbi.nlm.nih.gov/pubmed/17192847

 

Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress.                                                (abst – 2007)     http://www.ncbi.nlm.nih.gov/pubmed/17511970

 

Effect of Endocannabinoid System on the Neurogenic Function of Rat Corpus Cavernosum        (abst – 2007)  http://www.doaj.org/doaj?func=abstract&id=1150200&q1=endocannabinoid%20system&f1=all&b1=and& q2=&f2=all&recNo=26&uiLanguage=en

 

Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.                                                    (abst – 2007)  http://www.ncbi.nlm.nih.gov/pubmed/17459108

 

The endocannabinoid system               (news – 2007)

http://www.xagena.it/news/medicinenews_net_news/27e9efa7a852bcaa4d9fe0791d2d37b1.html

 

Marijuana-Like Brain Chemicals Work As Antidepressant              (news – 2007)

http://www.sciencedaily.com/releases/2007/11/071105120556.htm

 

Role seen for cannabis in helping to alleviate allergic skin disease                (news – 2007)

http://www.physorg.com/news106487623.html

 

CB1 Cannabinoid Receptor Inhibition: Promising Approach for Heart Failure? (full – 2008)                                  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669829/?tool=pmcentrez

 

N-arachidonylethanolamide-Induced Increase in Aqueous Humor Outflow Facility (full – 2008)                                http://www.iovs.org/cgi/content/full/49/10/4528

 

Expression of the Endocannabinoid System in Human First Trimester Placenta and Its Role in Trophoblast Proliferation                                                       (full – 2008)  http://endo.endojournals.org/content/149/10/5052.full?sid=f5b14012-9fbe-4f10-890c-386313060cf8

 

Pharmacological Inhibition of CB1 Cannabinoid Receptor Protects Against Doxorubicin- Induced Cardiotoxicity                                                 (full – 2008)      http://content.onlinejacc.org/cgi/content/full/50/6/528

 

Modulation of the Endocannabinoid System in Cardiovascular Disease            (full – 2008)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2568884/?tool=pmcentrez

 

Cannabinoid receptors and the regulation of bone mass               (full – 2008)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219540/?tool=pmcentrez

 

Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats    (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697765/?tool=pmcentrez

 

‘Entourage’ effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors.                                                                         (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597234/?tool=pubmed

 

Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids: Involvement of Regulatory T Cells                                                                   (full – 2008)  http://molpharm.aspetjournals.org/content/74/1/20.full?maxtoshow=&hits=80&RESULTFORMAT=&fullt ext=cannabinoid&searchid=1&FIRSTINDEX=320&resourcetype=HWCIT#content-block

 

Ulcerative colitis in AKR mice is attenuated by intraperitoneally administered anandamide.         (full – 2008)  http://www.jpp.krakow.pl/journal/archive/12_08/pdf/673_12_08_article.pdf

 

Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages         (full – 2008)  http://cardiovascres.oxfordjournals.org/content/81/4/805.full?sid=7d2438c4-a727-410f-870d-  4a971695b4fb

 

Endocannabinoids and the Control of Energy Homeostasis             (full – 2008)

http://www.jbc.org/content/283/48/33021.full?sid=931583b1-e797-43e0-8296-7fd75bb49403

 

Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion.                                          (full – 2008)

http://joe.endocrinology-journals.org/content/199/2/235.long

 

The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway                                                     (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2604798/?tool=pmcentrez

 

The anandamide analog, Met-F-AEA, controls human breast cancer cell migration via the RHOA/RHO kinase signaling pathway.                                                 (full – 2008)

http://erc.endocrinology-journals.org/cgi/content/full/15/4/965

 

Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling.                                                                      (full – 2008)  http://www.fasebj.org/content/22/10/3685.long

 

Role of cannabinoids and endocannabinoids in cerebral ischemia              (full – 2008)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2581413/?tool=pmcentrez

 

Endocannabinoid Dysregulation in the Pancreas and Adipose Tissue of Mice Fed With a High-fat Diet  (full – 2008)                           http://www.nature.com/oby/journal/v16/n3/full/oby2007106a.html

 

Endocannabinoids and nutrition.               (full – 2008)

http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01687.x/pdf

 

Mechanisms for Recycling and Biosynthesis of Endogenous Cannabinoids Anandamide and 2-Arachidonylglycerol                                                           (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2581634/?tool=pmcentrez

 

Endocannabinoids and nutrition.             (full – 2008)

http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01687.x/full

 

Role of endocannabinoids and their analogues in obesity and eating disorders. (abst – 2008)                                     http://www.ncbi.nlm.nih.gov/pubmed/19011363

 

Inhibition of anandamide hydrolysis by URB597 reverses abuse-related behavioral and neurochemical effects of nicotine in rats.                                                      (abst – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663803/?tool=pubmed

 

The endocannabinoid system: emotion, learning and addiction.              (abst – 2008)

http://www.ncbi.nlm.nih.gov/pubmed/18422832

 

Anandamide and neutrophil function in patients with fibromyalgia.             (abst – 2008)

http://www.ncbi.nlm.nih.gov/pubmed/18395993

 

Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum.     (abst – 2008)                         http://www.ncbi.nlm.nih.gov/pubmed/18204441

 

Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis. (abst – 2008)                                    http://www.ncbi.nlm.nih.gov/pubmed/18535023

 

Effect of anandamide in improving of the non-adrenergic non-cholinergic relaxation of the corpus cavernosum from diabetic rats                                                              (abst – 2008)  http://www.doaj.org/doaj?func=abstract&id=859448&q1=anandamide&f1=all&b1=and&q2=&f2=all&rec  No=25&uiLanguage=en

 

Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets.                                            (abst – 2008)        http://www.ncbi.nlm.nih.gov/pubmed/18343566

 

Understanding the effects of endogenous cannabinoids                 (news – 2008)

http://arstechnica.com/science/news/2008/11/understanding-the-effects-of-endogenous-cannabinoids.ars

 

Marijuana-Inspired Painkiller? New Chemical Pathway Discovered                (news – 2008)

http://www.sciencedaily.com/releases/2008/11/081123150249.htm

 

Endocannabinoids and the Heart              (full – 2009)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2728560/?tool=pmcentrez

 

Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation             (full – 2009)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664885/?tool=pmcentrez

 

Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress.                                                   (full – 2009)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716432/?tool=pubmed

 

Localisation and Function of the Endocannabinoid System in the Human Ovary (full – 2009)                                           http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2640464/?tool=pmcentrez

 

Changes in the Endocannabinoid System May Give Insight into new and Effective Treatments for Cancer          (full – 2009)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791688/?tool=pmcentrez

 

The biosynthesis of N-arachidonoyl dopamine (NADA), a putative endocannabinoid and endovanilloid, via conjugation of arachidonic acid with dopamine                                             (full – 2009)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757501/

 

Endogenous cannabinoids induce fever through the activation of CB1 receptors. (full – 2009)                                     http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765314/?tool=pubmed

 

Neuropathic Pain and Endocannabinoid-Degradation Blockade               (full – 2009)

http://jpet.aspetjournals.org/content/330/3/669.1.full?sid=af53ea87-ab4b-426e-9c7e-8f750e9c4a17

 

Biomarkers of Endocannabinoid System Activation in Severe Obesity             (full – 2009)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808340/?tool=pubmed

 

Endocannabinoids and Their Receptors as Targets for Obesity Therapy              (full – 2009)

http://endo.endojournals.org/cgi/content/full/150/6/2531#top

 

The endocannabinoid system in bull sperm and bovine oviductal epithelium: role of anandamide in sperm-oviduct interaction.                                                                 (full – 2009)

http://www.reproduction-online.org/cgi/content/full/137/3/403

 

Spatio-temporal expression patterns of anandamide-binding receptors in rat implantation sites: evidence for a role of the endocannabinoid system during the period of placental development   (full – 2009)                                    http://www.rbej.com/content/7/1/121

 

Modulation of motor and sensory pathways of the peristaltic reflex by cannabinoids. (full – 2009)                                      http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739820/?tool=pubmed

 

Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum (full – 2009)                           http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2009.05948.x/full

 

The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways                                                      (full – 2009)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689249/?tool=pubmed

 

Characterization of the Endocannabinoid System in Human Neuronal Cells and Proteomic Analysis of Anandamide-induced Apoptosis                                                  (full – 2009)  http://www.jbc.org/content/284/43/29413.full

 

Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner                                                  (full – 2009)  http://cardiovascres.oxfordjournals.org/content/85/1/56.full?sid=7d2438c4-a727-410f-870d-4a971695b4fb

 

Endocannabinoid-mediated control of synaptic transmission.             (full – 2009)

http://physrev.physiology.org/content/89/1/309.long

 

Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid. (full – 2009)                                   http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757605/?tool=pubmed

 

Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain. (full – 2009)

http://jpet.aspetjournals.org/content/330/3/902.full?sid=af53ea87-ab4b-426e-9c7e-8f750e9c4a17

 

Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain                                                                         (full – 2009)  http://www.molecularpain.com/content/5/1/35

 

The Endocannabinoid Anandamide: From Immunomodulation to Neuroprotection. Implications for Multiple Sclerosis                                                         (abst – 2009)  http://www.ncbi.nlm.nih.gov/pubmed/19647114

 

From endocannabinoid profiling to ‘endocannabinoid therapeutics’.              (abst – 2009)

http://www.ncbi.nlm.nih.gov/pubmed/19497779

 

Plasma endocannabinoid levels in multiple sclerosis.                (abst – 2009)

http://www.ncbi.nlm.nih.gov/pubmed/19695579

 

Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects.                                                 (abst – 2009)  http://www.ncbi.nlm.nih.gov/pubmed/19659925

 

Receptors for acylethanolamides-GPR55 and GPR119.              (full – 2009)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751869/?tool=pubmed

 

Pharmacological synergism between cannabinoids and paclitaxel in gastric cancer cell lines.         (abst – 2009)                       http://www.ncbi.nlm.nih.gov/pubmed/19394652

 

Circulating endocannabinoid concentrations during orthostatic stress              (abst – 2009)

www.ncbi.nlm.nih.gov/pubmed/19756829

 

Endocannabinoids prevent lysosomal membrane destabilisation evoked by treatment with β-amyloid in cultured rat cortical neurons                                                         (abst – 2009)  http://forum.grasscity.com/medical-marijuana-usage-applications/1029121-alzheimers-  study.html#post14325992

 

A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis                                                       (abst – 2009)  http://www.unboundmedicine.com/medline/ebm/record/19189054/abstract/A_metabolically_stable_analog  ue_of_anandamide_Met_F_AEA_inhibits_human_thyroid_carcinoma_cell_lines_by_activation_of_apopto sis_

 

Is GPR55 an anandamide receptor?                   (abst – 2009)

http://www.ncbi.nlm.nih.gov/pubmed/19647110

 

N-acylethanolamines, anandamide and food intake.              (abst – 2009)

http://www.ncbi.nlm.nih.gov/pubmed/19413995

 

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2                                                                 (full – 2010)  http://pharmrev.aspetjournals.org/content/62/4/588.full.pdf+html

 

Recent advances in the regulation of cholangiocarcinoma growth               (full – 2010)

http://ajpgi.physiology.org/content/299/1/G1.full

 

Cannabinoid Receptors as Target for Treatment of Osteoporosis: A Tale of Two Therapies           (full – 2010)                            http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001217/?tool=pubmed

 

Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism (full – 2010)                                    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260554/?tool=pubmed

 

Cannabinoid-mediated inhibition of recurrent excitatory circuitry in the dentate gyrus in a mouse model of temporal lobe epilepsy.                                                           (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871782/?tool=pubmed

 

Endocannabinoids Prevent β-Amyloid-mediated Lysosomal Destabilization in Cultured Neurons            (full – 2010)                    http://www.jbc.org/content/285/49/38543.full

 

 

Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls (full – 2010)                                     http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2010.00787.x/full

 

Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling.                                                                    (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872061/?tool=pubmed

 

A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats            (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2981070/?tool=pubmed

 

Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality.                                                            (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848893/?tool=pubmed

 

Antitumorigenic Effects of Cannabinoids beyond Apoptosis             (full – 2010)

http://jpet.aspetjournals.org/content/332/2/336.full?sid=af53ea87-ab4b-426e-9c7e-8f750e9c4a17

 

Endogenous cannabinoid signaling is essential for stress adaptation             (full – 2010)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889099/?tool=pmcentrez

 

Preservation of Striatal Cannabinoid CB1 Receptor Function Correlates with the Antianxiety Effects of Fatty Acid Amide Hydrolase Inhibition (full – 2010)  http://molpharm.aspetjournals.org/content/78/2/260.long

 

Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients                                                   (full – 2010)  http://www.lipidworld.com/content/9/1/43

 

The endocannabinoid system as a target for the treatment of neurodegenerative disease (full – 2010)                                      http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931550/?tool=pubmed

 

Alterations in the hippocampal endocannabinoid system in diet-induced obese mice. (full – 2010)                                         http://www.jneurosci.org/content/30/18/6273.long

 

Effects of a Commonly Occurring Genetic Polymorphism of Human CYP3A4 (I118V) on the Metabolism of Anandamide                                                   (full – 2010)  http://dmd.aspetjournals.org/content/38/11/2075.full

 

Cyclooxygenase-2 Mediates Anandamide Metabolism in the Mouse Brain             (full – 2010)

http://jpet.aspetjournals.org/content/335/2/380.full?sid=af53ea87-ab4b-426e-9c7e-8f750e9c4a17

 

Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients.                                                 (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868848/?tool=pubmed

 

Plasma anandamide and other N-acylethanolamines are correlated with their corresponding free fatty acid levels under both fasting and non-fasting conditions in women     (full – 2010)                           http://www.nutritionandmetabolism.com/content/7/1/49

 

Energetic Metabolism and Human Sperm Motility: Impact of CB1 Receptor Activation (full – 2010)                                    http://endo.endojournals.org/content/151/12/5882.full

 

Characterization of the Endocannabinoid System in Human Spermatozoa and Involvement of Transient Receptor Potential Vanilloid 1 Receptor in Their Fertilizing Ability   (full – 2010)

http://endo.endojournals.org/content/150/10/4692.full?sid=f5b14012-9fbe-4f10-890c-386313060cf8

 

Maternal Dietary Fat Determines Metabolic Profile and the Magnitude of Endocannabinoid Inhibition of the Stress Response in Neonatal Rat Offspring (full – 2010)

http://endo.endojournals.org/content/151/4/1685.full?sid=f9729cff-d221-42d4-81d8-8545db5df878

 

Inactivation of Anandamide Signaling: A Continuing Debate             (link to PDF- 2010)

http://www.mdpi.com/1424-8247/3/11/3355

 

From Fertilisation to Implantation in Mammalian Pregnancy—Modulation of Early Human Reproduction by the Endocannabinoid System                                                             (link to PDF – 2010)  http://www.mdpi.com/1424-8247/3/9/2910

 

The endogenous cannabinoid, anandamide, induces COX-2-dependent cell death in apoptosis-resistant colon cancer cells.                                                          (link to PDF – 2010)

http://www.spandidos-publications.com/ijo/37/1/187

 

Endocannabinoids and Human Sperm Cells              (link to PDF – 2010)

http://www.mdpi.com/1424-8247/3/10/3200

 

Endocannabinoids and Schizophrenia                 (link to PDF – 2010)

http://www.mdpi.com/1424-8247/3/10/3101

 

Effects of anandamide on polyamine levels and cell growth in human colon cancer cells (abst – 2010)                                     http://www.ncbi.nlm.nih.gov/pubmed/20682986

 

PP-014 Control of receptor expression in vagal afferent neurons by activation of cannabinoid 1 receptors                                                      (abst – 2010)  http://gut.bmj.com/cgi/content/meeting_abstract/59/1_MeetingAbstracts/A45-a?sid=0731f0e5-2071-4549-  be57-57f444307138

 

Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis.                                                 (abst – 2010)        http://www.ncbi.nlm.nih.gov/pubmed/19840245

 

Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea– specific role of oleoylethanolamide.                                          (abst – 2010)  http://www.ncbi.nlm.nih.gov/pubmed/20429051

 

 

Endogenous cannabinoids in liver disease: Many darts for a single target (abst – 2010)                                     http://www.ncbi.nlm.nih.gov/pubmed/19758727

 

Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels.       (abst – 2010)  http://www.unboundmedicine.com/medline/ebm/record/19847654/abstract/Non_CB1_non_CB2_receptors

_for_endocannabinoids_plant_cannabinoids_and_synthetic_cannabimimetics:_focus_on_G_protein_couple d_receptors_and_transient_receptor_potential_channels_

 

The Multiplicity of Action of Cannabinoids: Implications for Treating Neurodegeneration.           (abst – 2010)                                              http://www.ncbi.nlm.nih.gov/pubmed/20875047

 

Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders?                                                             (abst – 2010)  http://www.unboundmedicine.com/medline/ebm/record/20512266/abstract/%5BPharmacological_exploitat ion_of_the_endocannabinoid_system:_new_perspectives_for_the_treatment_of_depression_and_anxiety_d isorders%5D_

 

Anandamide extends platelets survival through CB(1)-dependent Akt signaling. (abst – 2010)                                                   http://www.ncbi.nlm.nih.gov/pubmed/19936621

 

Interaction between anandamide and sphingosine-1-phosphate in mediating vasorelaxation in rat coronary artery                                                                         (abst – 2010)  http://www.unboundmedicine.com/medline/ebm/record/20718749/abstract/Interaction_between_anandami de_and_sphingosine_1_phosphate_in_mediating_vasorelaxation_in_rat_coronary_artery_

 

Localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity.                                                              (abst – 2010)  http://www.ncbi.nlm.nih.gov/pubmed/19147270

 

Anandamide and AM251, via water, modulate food intake at central and peripheral level in fish. (abst – 2010)                          http://www.ncbi.nlm.nih.gov/pubmed/19800340

 

Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain.     (abst – 2010)                         http://www.ncbi.nlm.nih.gov/pubmed/20353771

 

The endocannabinoid system modulates the valence of the emotion associated to food ingestion (abst – 2010)

http://onlinelibrary.wiley.com/doi/10.1111/j.1369-1600.2010.00271.x/abstract

 

Compound boosts marijuana-like chemical in the body to relieve pain at injury site (news – 2010)                                       http://www.eurekalert.org/pub_releases/2010-09/uoc–cbm092010.php

 

Chocolate: The Good, the Bad and the Angry               (news – 2010)

http://www.psychologytoday.com/blog/your-brain-food/201011/chocolate-the-good-the-bad-and-the-angry

 

Nutritional Facts on Raw Cacao Beans                (news – 2010)

http://www.livestrong.com/article/279743-nutritional-facts-on-raw-cacao-beans/

 

Cocoa and the Search for Dietary Cannabinoids               (news – 2010)

http://www.examiner.com/article/cocoa-and-the-search-for-dietary-cannabinoids

 

Receptors triggered by pot may lessen hit from chronic stress               (news – 2010)

http://arstechnica.com/science/2010/05/brains-endogenous-cannabinoids-lessen-impact-of-stress/

 

Increasing the body’s (but not brain’s) cannabinoids dulls pain                (news – 2010)

http://arstechnica.com/science/2010/10/increasing-the-bodys-but-not-brains-cannabinoids-dulls-pain/

 

Painkilling System in Brain: Too Much of a Good Thing?                  (news – 2010)

http://www.sciencedaily.com/releases/2010/08/100824151036.htm

 

Research Reaps Reefer Madness               (news – 2010)

http://www.newuniversity.org/2010/10/news/research-reaps-reefer-madness/

 

A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development      (full – 2011)                                    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215906/

 

Dual inhibition of alpha/beta hydrolase domain 6 and fatty acid amide hydrolase increases endocannabinoid levels in neurons.                                                                       (full – 2011)  http://www.jbc.org/content/early/2011/06/10/jbc.M110.202853.long

 

A catalytically silent FAAH-1 variant drives anandamide transport in neurons. (full – 2011)                                   http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245783/

 

Anandamide inhibits Theiler’s virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB1 receptors.    (full – 2011)

http://www.jneuroinflammation.com/content/pdf/1742-2094-8-102.pdf

 

Anandamide capacitates bull spermatozoa through CB1 and TRPV1 activation. (full – 2011)                                    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037938/?tool=pubmed

 

Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibition.     (full – 2011)                    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227620/?tool=pubmed

 

Targeting the CB2 cannabinoid receptor in osteoporosis               (full – 2011)

http://www.expert- reviews.com/doi/full/10.1586/eem.11.2?prevSearch=Keyword%253A%2528%2522cannabinoid%2522%2  529&searchHistoryKey=

 

Endocannabinoid system in cardiovascular disorders – new pharmacotherapeutic opportunities    (full – 2011)

http://www.jpbsonline.org/article.asp?issn=0975-  7406;year=2011;volume=3;issue=3;spage=350;epage=360;aulast=Cunha

 

The endocannabinoid system and cancer: therapeutic implication            (full – 2011)

http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01327.x/full

 

Cannabinoid and GABA modulation of sympathetic nerve activity and blood pressure in the dorsal periaqueductal gray of the rat                                                        (full – 2011)  http://ajpregu.physiology.org/content/301/6/R1765.full

 

Increasing Antiproliferative Properties of Endocannabinoids in N1E-115 Neuroblastoma Cells through Inhibition of Their Metabolism.                                                           (full – 2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203169/?tool=pubmed

 

Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice                                                           (full – 2011)  http://www.nutritionandmetabolism.com/content/8/1/51

 

The activity of the endocannabinoid metabolising enzyme fatty acid amide hydrolase in subcutaneous adipocytes correlates with BMI in metabolically healthy humans

(full – 2011)                http://www.lipidworld.com/content/10/1/129

 

Anandamide-loaded nanoparticles: preparation and characterization.               (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21425945

 

Cannabinoid-2 Receptor Activation Protects against Infarct and Ischemia/Reperfusion Heart Injury.      (abst – 2011)                         http://www.ncbi.nlm.nih.gov/pubmed/22113346

 

Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liver                                                            (abst  – 2011)  http://www.pnas.org/content/108/15/6323.abstract?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=  cannabinoid&searchid=1&FIRSTINDEX=80&sortspec=date&resourcetype=HWCIT

 

Cannabinoid applications in glaucoma.               (abst – 2011)  http://www.unboundmedicine.com/medline/ebm/record/21414525/abstract/Cannabinoid_applications_in_g  laucoma_

 

A cannabinoid ligand, anandamide, exacerbates endotoxin-induced uveitis in rabbits. (abst – 2011)                                     http://www.ncbi.nlm.nih.gov/pubmed/21848425

 

An amyloid β(42)-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer’s disease                                                        (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21546126/abstract/An_amyloid_%CE%B2_42         d

ependent_deficit_in_anandamide_mobilization_is_associated_with_cognitive_dysfunction_in_Alzheimer%  27s_disease_

 

Arachidonoyl ethanolamide (AEA)-induced apoptosis is mediated by J-series prostaglandins and is enhanced by fatty acid amide hydrolase (FAAH) blockade. (abst – 2011)

http://www.unboundmedicine.com/medline/ebm/record/21432910/abstract/Arachidonoyl_ethanolamide__

 

 

 

 

Intracellular Cannabinoid Type 1 (CB1) Receptors Are Activated by Anandamide (abst – 2011)

http://www.jbc.org/content/286/33/29166.abstract?sid=2c3b88ec-b6e6-4245-a171-2e24c17b5e8b

 

Abnormal anandamide metabolism in celiac disease.              (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/22209002

 

Inhibition of cannabinoid metabolic enzymes reduces NSAID-induced gastric pathology (abst – 2011)  http://www.fasebj.org/cgi/content/meeting_abstract/25/1_MeetingAbstracts/807.1?maxtoshow=&hits=80&  RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=80&sortspec=date&resourcetype

=HWCIT

 

Pharmacological elevation of anandamide impairs short-term memory by altering the neurophysiology in the hippocampus.                                                      (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/21767554

 

The fatty acid amide hydrolase inhibitor URB 597: interactions with anandamide in rhesus monkeys.      (abst – 2011)  http://www.unboundmedicine.com/medline/ebm/record/21449917/abstract/The_fatty_acid_amide_hydrolas e_inhibitor_URB_597:_interactions_with_anandamide_in_rhesus_monkeys_

 

Triphasic blood pressure responses to cannabinoids: do we understand the mechanism? (abst – 2011)                                     http://www.ncbi.nlm.nih.gov/pubmed/22022923

 

Endocannabinoid CB1 receptors modulate visual output from the thalamus. (abst – 2011)                                    http://www.ncbi.nlm.nih.gov/pubmed/21773721

 

Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines.                                                      (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/21995886

 

Anandamide inhibits the growth of colorectal cancer cells through CB1 and lipid rafts (abst – 2011)                                     http://www.ncbi.nlm.nih.gov/pubmed/21575494

 

Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.                                                    (abst – 2011)  http://www.unboundmedicine.com/medline/ebm/record/21145341/abstract/Inhibition_of_endocannabinoid

_catabolic_enzymes_elicits_anxiolytic_like_effects_in_the_marble_burying_assay_

 

The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats.

(abst – 2011)                http://www.ncbi.nlm.nih.gov/pubmed/21557729

 

Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice.                                                            (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/21740924

 

 

Effects of exercise stress on the endocannabinoid system in humans under field conditions.         (abst – 2011)                               http://www.ncbi.nlm.nih.gov/pubmed/22101870

 

Intense exercise increases circulating endocannabinoid and BDNF levels in humans— Possible implications for reward and depression                                                           (abst – 2011)  http://www.psyneuen-journal.com/article/PIIS0306453011002873/abstract?rss=yes

 

The endocannabinoid system in the cancer therapy: an overview.             (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21428888

 

Effect of an Acute Consumption of a Moderate Amount of Ethanol on Plasma Endocannabinoid Levels in Humans                                                                                (abst – 2011)  http://alcalc.oxfordjournals.org/content/47/3/226.short?rss=1

 

Effect of capacitation on the endocannabinoid system of mouse sperm.             (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21723369

 

Marijuana Compound Treats Multiple Health Issues               (news – 2011)

http://www.foxnews.com/health/2010/03/10/cannabis-deficient/

 

New Way to Boost Potency of Natural Pain Relief Chemical in Body              (news – 2011)

http://www.sciencedaily.com/releases/2011/11/111121142501.htm

 

Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids

(full – 2012)                   http://link.springer.com/article/10.1007/s12035-012-8299-0/fulltext.html

 

Serum contents of endocannabinoids are correlated with blood pressure in depressed women.     (full – 2012)                          http://www.lipidworld.com/content/pdf/1476-511X-11-32.pdf

 

Endocannabinoids Stimulate Human Melanogenesis via Type-1 Cannabinoid Receptor (full – 2012)                                      http://www.jbc.org/content/early/2012/03/19/jbc.M111.314880.full.pdf+html

 

Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liver                                                          (full – 2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3076854/?tool=pubmed

 

Role of cannabinoids in the regulation of bone remodeling                (full – 2012)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499879/

 

Cannabinoid Receptor 2-Mediated Attenuation of CXCR4-Tropic HIV Infection in Primary CD4+ T Cells       (full – 2012)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0033961

 

Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain         (full – 2012)                                                      http://jpet.aspetjournals.org/content/338/1/114.full

 

 

Endocannabinoids measurement in human saliva as potential biomarker of obesity. (full – 2012)                                   http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409167/?tool=pubmed

 

Anandamide Induces Sperm Release from Oviductal Epithelia through Nitric Oxide Pathway in Bovines.           (full – 2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281848/?tool=pubmed

 

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.           (full – 2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316151/?tool=pubmed

 

Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the “Mirror Effect” of Schizophrenia.                                                            (full – 2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457074/

 

A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional–motivational reactivity                                                           (full – 2012)  http://link.springer.com/article/10.1007/s00213-012-2785-y/fulltext.html

 

The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation (full – 2012)                                    http://www.jneuroinflammation.com/content/9/1/79

 

Review article: Endocannabinoids in neuroendopsychology: multiphasic control of mitochondrial function         (full – 2012)  http://rstb.royalsocietypublishing.org/content/367/1607/3342.full?sid=dd42995f-c629-4f8c-86a0-  5e962e352fda

 

Cannabinoid modulation of neuroinflammatory disorders.             (full – 2012)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386505/

 

The endocannabinoid, anandamide, augments Notch-1 signaling in cultured cortical neurons exposed to amyloid-beta and in the cortex of aged rats.                                                               (full – 2012)  http://www.jbc.org/content/early/2012/08/13/jbc.M112.350678.long

 

Early Endogenous Activation of CB1 and CB2 Receptors after Spinal Cord Injury Is a Protective Response Involved in Spontaneous Recovery                                                (full – 2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496738/

 

Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy. (full – 2012)                                     http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366638/

 

Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity. (full – 2012)                                  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458187/

 

Excess of the endocannabinoid anandamide during lactation induces overweight, fat accumulation and insulin resistance in adult mice                                                          (full – 2012)

 

http://www.dmsjournal.com/content/4/1/35

 

Type 2 Diabetes Associated Changes in the Plasma Non-Esterified Fatty Acids, Oxylipins and Endocannabinoids                                                                        (full – 2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493609/

 

GPR18 in microglia: implications for the CNS and endocannabinoid system signaling (full – 2012)                                   http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02019.x/full

 

So what do we call GPR18 now?               (full – 2012)

http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01731.x/full

 

The dynamic nature of type 1 cannabinoid receptor (CB1) gene transcription (full – 2012)                                      http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02175.x/full

 

Phytoestrogens Enhance the Vascular Actions of the Endocannabinoid Anandamide in Mesenteric Beds of Female Rats                                                          (full – 2012)  http://www.hindawi.com/journals/ijht/2012/647856/

 

Cannabinoid Receptor Type 1 (CB1) Activation Inhibits Small GTPase RhoA Activity and Regulates Motility of Prostate Carcinoma Cells                                                          (full – 2012)  http://endo.endojournals.org/content/153/1/29.full

 

Bidirectional regulation of endocannabinoid signaling in the amygdala contributes to activation and adaptation of the stress response                                                              (link to PDF – 2012)  http://www.doaj.org/doaj?func=abstract&id=1152480&q1=cannabinoid&f1=all&b1=and&q2=&f2=all&re cNo=4&uiLanguage=en

 

Endocannabinoids in stressed humans                (link to PDF – 2012)  http://www.doaj.org/doaj?func=abstract&id=1152482&q1=cannabinoid&f1=all&b1=and&q2=&f2=all&re cNo=2&uiLanguage=en

 

Positron emission tomography offers new perspectives for evidence-based treatment development in PTSD                                                     (link to PDF – 2012)  http://www.doaj.org/doaj?func=abstract&id=1152483&q1=endocannabinoid&f1=all&b1=and&q2=&f2=al  l&recNo=2&uiLanguage=en

 

Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system  (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/23108547

 

Monoacylglycerol lipase – a target for drug development?               (abst – 2012)

http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.01950.x/abstract

 

Revisiting CB1 Receptor as Drug Target in Human Melanoma.                (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/22447182

 

Arachidonoyl ethanolamide (AEA)-induced apoptosis is mediated by J-series prostaglandins and is enhanced by fatty acid amide hydrolase (FAAH) blockade.

 

(abst – 2012)                http://www.ncbi.nlm.nih.gov/pubmed/21432910

 

Dynamic changes to the endocannabinoid system in models of chronic pain (abst – 2012)                                     http://www.ncbi.nlm.nih.gov/pubmed/23108548

 

Effect of omega-3 polyunsaturated fatty acids on the endocannabinoid system in osteoblast-like cells and muscle                                                                  (abst – 2012)  http://docs.lib.purdue.edu/dissertations/AAI3444794/

 

Review article: The endocannabinoid system in normal and pathological brain ageing (abst – 2012)                                     http://www.ncbi.nlm.nih.gov/pubmed/23108550

 

Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro.                                                           (abst – 2012)    http://www.ncbi.nlm.nih.gov/pubmed/22233683

 

Review article: Why do cannabinoid receptors have more than one endogenous ligand? (abst – 2012)                                     http://www.ncbi.nlm.nih.gov/pubmed/23108541

 

Endocannabinoids at the synapse a decade after the Dies Mirabilis (29 March 2001): what we still do not know.                                                        (abst – 2012)     http://www.ncbi.nlm.nih.gov/pubmed/22289914

 

Vascular metabolism of anandamide to arachidonic acid affects myogenic constriction in response to intraluminal pressure elevation.                                                       (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22285599

 

Inhibitors of the Endocannabinoid-Degrading Enzymes, or how to Increase Endocannabinoid’s Activity by Preventing their Hydrolysis.                                                                   (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22280341

 

Effects of the anandamide uptake blocker AM404 on food intake depend on feeding status and route of administration.                                              (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22133635

 

Endocannabinoid analogues exacerbate marble-burying behavior in mice via TRPV1 receptor.      (abst – 2012)                             http://www.ncbi.nlm.nih.gov/pubmed/22248639

 

Changes of Blood Endocannabinoids during Anaesthesia: a Special Case for Fatty Acid Amide Hydrolase Inhibition by Propofol?                                               (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22242687

 

Effect of an Acute Consumption of a Moderate Amount of Ethanol on Plasma Endocannabinoid Levels in Humans.                                                                             (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22278319

 

Equipotent Inhibition of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase – Dual Targets of the Endocannabinoid System to Protect against Seizure Pathology. (abst – 2012)                                      http://www.ncbi.nlm.nih.gov/pubmed/22270809

 

Alteration of endocannabinoid system in human gliomas.                (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/22176552

 

The Endocannabinoids Anandamide and Virodhamine Modulate the Activity of the Candidate Cannabinoid Receptor GPR55.                                                      (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22454039

 

Effects of Peptide and Lipid Endocannabinoids on Arthritic Pain at Spinal Level. (abst – 2012)                                      http://www.ncbi.nlm.nih.gov/pubmed/22451592

 

Cortisol-mediated adhesion of synovial fibroblasts is dependent on the degradation of anandamide and activation of the endocannabinoid system.                                                             (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22933357

 

Circulating Endocannabinoid Concentrations and Sexual Arousal in Women. (abst – 2012)                                            http://www.ncbi.nlm.nih.gov/pubmed/22462722

 

Essential fatty acids and lipid mediators. Endocannabinoids                 (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/22730630

 

Anandamide Induces Matrix Metalloproteinase-2 Production through Cannabinoid-1 Receptor and Transient Receptor Potential Vanilloid-1 in Human Dental Pulp Cells in Culture.      (abst – 2012)                               http://www.ncbi.nlm.nih.gov/pubmed/22595113

 

Vascular metabolism of anandamide to arachidonic acid affects myogenic constriction in response to intraluminal pressure elevation.                                                       (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22285599

 

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.           (abst – 2012)                         http://www.ncbi.nlm.nih.gov/pubmed/22832859?dopt=Abstract

 

Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives.                                              (abst – 2012)        http://www.ncbi.nlm.nih.gov/pubmed/22280339

 

Inhibition Of Fatty Acid Amide Hydrolase Produces Anti-Tussive Effects In Guinea- Pigs: Evidence For Elevated Fatty Acid Amides Acting Via Cannabinoid Receptors On Airway Sensory Nerves          (abst – 2012)  http://ajrccm.atsjournals.org/cgi/reprint/185/1_MeetingAbstracts/A2149?maxtoshow=&hits=25&RESULT   FORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=130&sortspec=date&resourcetype=HWCI   T

 

Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour.                                                       (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/11982628

 

THE CO-EXPRESSION OF THE ENDOCANNABINOID SYSTEM AND THE RANK/RANKL SIGNALLING PATHWAY IN HUMAN BONE AND OSTEOCLAST CULTURE      (abst – 2012)

 

http://www.bjjprocs.boneandjoint.org.uk/content/94-  B/SUPP_XVIII/7.abstract?maxtoshow=&hits=25&RESULTFORMAT=&fulltext=cannabinoid&searchid= 1&FIRSTINDEX=130&sortspec=date&resourcetype=HWCIT

 

Anti-Inflammatory Effect of the Endocannabinoid Anandamide in Experimental Periodontitis and Stress in the Rat.                                                                (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22777139

 

The Novel Reversible Fatty Acid Amide Hydrolase Inhibitor ST4070 Increases Endocannabinoid Brain Levels and Counteracts Neuropathic Pain in Different Animal Models (abst – 2012)  http://jpet.aspetjournals.org/content/342/1/188.abstract?sid=ae58f15a-06bb-4a81-b850-61bb89fd59f5

 

Medial prefrontal cortex endocannabinoid system modulates baroreflex activity through CB1 receptors  (abst – 2012)  http://ajpregu.physiology.org/content/302/7/R876.abstract?sid=952e2125-0502-477c-b603-30f0f3e51b55

 

Analgesic effects of cannabinoids on central pain syndrome               (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/22359935

 

Hedonic eating is associated with increased peripheral levels of ghrelin and the endocannabinoid 2-arachidonoyl-glycerol in healthy humans: a pilot study. (abst – 2012)       http://www.ncbi.nlm.nih.gov/pubmed/22442280

 

Pharmacological inhibition of endocannabinoid degradation modulates the expression of inflammatory mediators in the hypothalamus following an immunological stressor.

(abst – 2012)                 http://www.ncbi.nlm.nih.gov/pubmed/21952131

 

Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in muller glia during inflammation.                                                                 (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22807196

 

Endocannabinoids reduce cerebral damage after hypoxic-ischemic injury in perinatal rats. (abst – 2012)                                   http://www.ncbi.nlm.nih.gov/pubmed/22841538

 

The Endocannabinoid System and the Brain.              (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/22804774

 

“Redundancy” of endocannabinoid inactivation: new challenges and opportunities for pain control.        (abst – 2012)                         http://www.ncbi.nlm.nih.gov/pubmed/22860203

 

Determination of the two major endocannabinoids in human plasma by μ-SPE followed by HPLC-MS/MS.                                             (abst – 2012)         http://www.ncbi.nlm.nih.gov/pubmed/22847477

 

Acetaminophen, pesticide, and diethylhexyl phthalate metabolites, anandamide, and fatty acids in deciduous molars: potential biomarkers of perinatal exposure. (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22805989

 

Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids.

(abst – 2012)                http://www.ncbi.nlm.nih.gov/pubmed/22801993

 

The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity.                                                       (abst – 2012)        http://www.ncbi.nlm.nih.gov/pubmed/22917662

 

Anandamide Transforms Noncopulating Rats into Sexually Active Animals. (abst – 2012)                                   http://www.ncbi.nlm.nih.gov/pubmed/22906359

 

Modulation of sweet responses of taste receptor cells.               (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/22947916

 

Serum Metabolic Profiling Study of Hepatocellular Carcinoma Infected with Hepatitis B or Hepatitis C Virus by Using Liquid Chromatography-Mass Spectrometry.

(abst – 2012)               http://www.ncbi.nlm.nih.gov/pubmed/22946841

 

Evaluation of the endogenous cannabinoid system in mediating the behavioral effects of dipyrone (metamizol) in mice.                                                    (abst – 2012)     http://www.ncbi.nlm.nih.gov/pubmed/22954646

 

The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity.                                           (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22943701

 

Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats. (abst – 2012)           http://www.ncbi.nlm.nih.gov/pubmed/22959964

 

Anti-proliferative effects of anandamide in human hepatocellular carcinoma cells. (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22970038

 

The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB(1) and FAAH-independent mechanisms.                                                          (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22970888

 

Modulation of low-voltage-activated T-type Ca(2+) Channels.              (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/22975282

 

Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB(1) receptor antagonists.      (abst – 2012)                                               http://www.ncbi.nlm.nih.gov/pubmed/22990678

 

Anandamide enhances expression of heat shock protein 72 to protect against ischemia- reperfusion injury in rat heart.                                                    (abst – 2012)     http://www.ncbi.nlm.nih.gov/pubmed/23007622

 

Effects of parabolic flight and spaceflight on the endocannabinoid system in humans. (abst – 2012)                                     http://www.ncbi.nlm.nih.gov/pubmed/23023882

 

 

Circulating anandamide and blood pressure in patients with obstructive sleep apnea. (abst – 2012)                                         http://www.ncbi.nlm.nih.gov/pubmed/23032139

 

A potential role for GPR55 in gastrointestinal functions.             (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/23063456

 

Differences in the endocannabinoid system of sperm from fertile and infertile men. (abst – 2012)                                     http://www.ncbi.nlm.nih.gov/pubmed/23082196

 

The Volitional Nature of Nicotine Exposure Alters Anandamide and Oleoylethanolamide Levels in the Ventral Tegmental Area.                                                      (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/23169348

 

Essential fatty acids and lipid mediators. Endocannabinoids                 (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/22730630

 

CB1 receptor activation in the nucleus accumbens core impairs contextual fear learning. (abst – 2012)                                    http://www.ncbi.nlm.nih.gov/pubmed/23018128

 

Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: Effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.   (abst – 2012)                                             http://www.ncbi.nlm.nih.gov/pubmed/23127915

 

The evolution and comparative neurobiology of endocannabinoid signaling (abst  – 2012)                                        http://www.ncbi.nlm.nih.gov/pubmed/23108540

 

The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity.                                                      (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22917662?dopt=Abstract

 

Multiple functions of endocannabinoid signaling in the brain.              (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/22524785?dopt=Abstract

 

Optimized synthesis and characterization of N-acylethanolamines and O- acylethanolamines, important family of lipid-signalling molecules.                                                                                     (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22850591?dopt=Abstract

 

Anandamide regulates the expression of GnRH1, GnRH2, and GnRH-Rs in frog testis (abst – 2012)                                        http://www.ncbi.nlm.nih.gov/pubmed/22669247

 

Ectopic pregnancy is associated with high anandamide levels and aberrant expression of FAAH and CB1 in fallopian tubes.                                                 (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22701012?dopt=Abstract

 

The role of endocannabinoids in gonadal function and fertility along the evolutionary axis.           (abst – 2012)                      http://www.ncbi.nlm.nih.gov/pubmed/22305972

 

 

Temporal changes in N-acylethanolamine content and metabolism throughout the peri- adolescent period                                         (abst – 2012)      http://onlinelibrary.wiley.com/doi/10.1002/syn.21609/abstract

 

The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB1 and FAAH-independent mechanisms                                                         (abst – 2012)  http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02208.x/abstract

 

The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity                                               (abst – 2012)  http://onlinelibrary.wiley.com/doi/10.1111/j.1467-789X.2012.01026.x/abstract

 

TRPV1-mediated calcium signal couples with cannabinoid receptors and sodium-calcium exchangers in rat odontoblasts.                                               (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22656960?dopt=Abstract

 

Acetaminophen, pesticide, and diethylhexyl phthalate metabolites, anandamide, and fatty acids in deciduous molars: potential biomarkers of perinatal exposure (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22805989

 

Anti-Inflammatory Effect of the Endocannabinoid Anandamide in Experimental Periodontitis and Stress in the Rat                                                                        (abst – 2012)  http://content.karger.com/produktedb/produkte.asp?doi=339113

 

Anandamide Induces Matrix Metalloproteinase-2 Production through Cannabinoid-1 Receptor and Transient Receptor Potential Vanilloid-1 in Human Dental Pulp Cells in Culture       (abst – 2012)                       http://www.jendodon.com/article/PIIS0099239912002191/abstract?rss=yes

 

Acute Stress Increases Circulating Anandamide and Other N-Acylethanolamines in Healthy Humans     (abst – 2012)                                 http://www.ncbi.nlm.nih.gov/pubmed/22763622

 

Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity                                                              (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22688188

 

Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice.                                                                   (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/21883147

 

The Contractile Effect of Anandamide in the Guinea-Pig Small Intestine is Mediated by Prostanoids but not TRPV1 Receptors or Capsaicin-Sensitive Nerves. (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/23216932

 

CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation                                                        (abst – 2012)  http://onlinelibrary.wiley.com/doi/10.1002/glia.22366/abstract

 

Acute reduction of anandamide-hydrolase (FAAH) activity is coupled with a reduction of nociceptive pathways facilitation in medication-overuse headache subjects after withdrawal treatment.   (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22670561?dopt=Abstract

 

β−Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors    (abst – 2012)

http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.01889.x/abstract

 

The endocannabinoid, anandamide, augments Notch-1 signaling in cultured cortical neurons exposed to amyloid-β and in the cortex of aged rats.                                                               (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22891244

 

The Endocannabinoids Anandamide and Virodhamine Modulate the Activity of the Candidate Cannabinoid Receptor GPR55                                                        (abst – 2012)  http://link.springer.com/article/10.1007%2Fs11481-012-9351-6#page-1

 

The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear- conditioned analgesia and controls fear expression in the presence of nociceptive tone (abst – 2012)                                    http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01478.x/abstract

 

The endocannabinoid system: a key modulator of emotions and cognition             (abst – 2012)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490098/

 

Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy.                                                                (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/23206503

 

Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells  (abst – 2012)  http://www.ejcancer.info/article/PIIS095980491200216X/abstract?rss=yes

 

Revisiting CB1 receptor as drug target in human melanoma.                (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/22447182

 

Tumour epithelial expression levels of endocannabinoid markers modulates the value of endoglin-positive vascular density as a prognostic marker in prostate cancer.

(abst – 2012)                http://www.ncbi.nlm.nih.gov/pubmed/23262399

 

Uncovering a role for endocannabinoid signaling in autophagy in preimplantation mouse embryos            (abst – 2012)                    http://molehr.oxfordjournals.org/content/19/2/93.abstract

 

Endocannabinoid system and mood disorders: Priming a target for new therapies. (abst – 2012)                                      http://www.ncbi.nlm.nih.gov/pubmed/23261685

 

‘Runner’s High’ may have played role in evolutionary history of humans              (news – 2012)

http://in.news.yahoo.com/runners-high-may-played-role-evolutionary-history-humans-105030765.html

 

 

Do we know if marijuana or narcotics adversely affect sleep?                  (news – 2012)

http://www.aafp.org/online/en/home/cme/aafpcourses/conferences/aafplivecme/sleepdisorders/faq/question

-14.html

 

Marijuana Compound Treats Schizophrenia with Few Side Effects: Clinical Trial (news – 2012)                                         http://www.mhhub.com/archives/16603

 

Cannnabinoids, Breast Milk, and Development                  (news – 2012)

http://www.examiner.com/article/cannnabinoids-breast-milk-and-development

 

Cannabinoids for the Treatment of Neuropathic Pain               (news – 2012)

http://www.medscape.com/viewarticle/739103_3

 

Metabolisms of endocannabinoids and related N-acylethanolamines: Canonical and alternate pathways  (full – 2013)                                   http://onlinelibrary.wiley.com/doi/10.1111/febs.12152/pdf

 

THE ENDOCANNABINOID SYSTEM PROVIDES AN AVENUE FOR EVIDENCE- BASED TREATMENT DEVELOPMENT FOR PTSD                                                          (1st page – 2013)

http://onlinelibrary.wiley.com/doi/10.1002/da.22031/abstract

 

CB1 and CB2 Cannabinoid Receptor Agonists Induce Peripheral Antinociception by Activation of the Endogenous Noradrenergic System.                                        (abst – 2013)  http://www.ncbi.nlm.nih.gov/pubmed/23302980

 

Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor.           (abst – 2013)                   http://www.ncbi.nlm.nih.gov/pubmed/23150578

 

The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23298518

 

Endocannabinoid/GABA interactions in the entopeduncular nucleus modulates alcohol intake in rats.     (abst – 2013)                          http://www.ncbi.nlm.nih.gov/pubmed/23291357

 

Modulation by 17β-estradiol of anandamide vasorelaxation in normotensive and hypertensive rats: a role for TRPV1 but not fatty acid amide hydrolase.                                                                      (abst – 2013)  http://www.ncbi.nlm.nih.gov/pubmed/23340220

 

Inhibition Of Fatty Acid Amide Hydrolase Activates Nrf2 Signaling And Induces Heme Oxygenase 1 Transcription In Breast Cancer Cells.                                       (abst – 2013)  http://www.ncbi.nlm.nih.gov/pubmed/23347118

 

Type-1 (CB(1)) Cannabinoid Receptor Promotes Neuronal Differentiation and Maturation of Neural Stem Cells.                                                                      (abst – 2013)  http://www.ncbi.nlm.nih.gov/pubmed/23372698

 

Elevated Anandamide and Related N-Acylethanolamine Levels Occur in the Peripheral Blood of Women With Ectopic Pregnancy and Are Mirrored by Changes in Peripheral Fatty Acid Amide Hydrolase Activity.    (abst – 2013)  http://www.ncbi.nlm.nih.gov/pubmed/23372171

 

Involvement of nitric oxide through endocannabinoids release in microglia activation during the course of CNS regeneration in the medicinal leech.                                                                     (abst – 2013)  http://www.ncbi.nlm.nih.gov/pubmed/23355252

 

The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis.                                                                       (abst – 2013)  http://www.ncbi.nlm.nih.gov/pubmed/23373571

 

Drug design for neuropathic pain regulation from traditional chinese medicine. (abst – 2013)                                        http://www.ncbi.nlm.nih.gov/pubmed/23378894

 

Prostaglandin ethanolamides attenuate damage in a human explant colitis model (abst – 2013)                                            http://www.ncbi.nlm.nih.gov/pubmed/23380599

 

Nicotine-Induced Neuroprotection Against Ischemic Injury Involves Activation of Endocannabinoid System in Rats                                                                   (abst – 2013)  http://link.springer.com/article/10.1007/s11064-012-0927-6

 

Rapid Glucocorticoid-Induced Activation of TRP and CB1 Receptors Causes Biphasic Modulation of Glutamate Release in Gastric-Related Hypothalamic Preautonomic Neurons.  (abst – 2013)                                    http://www.ncbi.nlm.nih.gov/pubmed/23386808

 

Signaling cross-talk between cannabinoid and muscarinic systems actives Rho-kinase and increases the contractile responses of the bovine ciliary muscle                                                          (abst – 2013)  http://www.ncbi.nlm.nih.gov/pubmed/23396229

 

Biosynthetic Pathways of Bioactive N-Acylethanolamines in Brain.                       (abst – 2013)

http://www.ncbi.nlm.nih.gov/pubmed/23394527

 

Taste sensitivity to 6-n-propylthiouracil is associated with endocannabinoid plasma levels in normal-weight individuals.                                                    (abst – 2013)  http://www.ncbi.nlm.nih.gov/pubmed/23398921

Share a link for

1 Comment

  1. What’s Going down i’m new to this, I stumbled upon this I’ve discovered It positively useful and it has helped me out loads. I’m hoping to give a contribution & assist other customers like its helped me. Great job.

Leave a Reply

Your email address will not be published.

*

© 2019 Debbie's Place

Powered by

www.420.ag